Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals [Phase 1, Phase 2]

View source ↗

Summary

An exploratory Phase 1/2 clinical trial evaluating LP-98 injections in ART-naive individuals with HIV; the study is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LP-98

Snippet

Sponsor: Shanxi Kangbao Biological Product Co., Ltd. | Conditions: HIV | Phase 1, Phase 2 | Status: RECRUITING